53,9 %The HPV vaccination rate among adolescent girls aged 9–17 was 53.9%.
Nigeriainfection à HPVpublié 2025PloS onePubMeddocument de 4 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
8 823 evidences · page 181 / 353
53,9 %The HPV vaccination rate among adolescent girls aged 9–17 was 53.9%.
Nigeriainfection à HPVpublié 2025PloS onePubMeddocument de 4 observations
344 patients28 jours après le début du traitement, chez 344 patients présentant une parasitémie persistante, 9 avaient été traités par Artemisia annua et 25 par Artemisia afra.
NigeriaparasitémieHAL · Unilimdocument de 173 observations
24 individualsAmong the 30 selected young people living with HIV, 24 had viral load suppression at the second test.
NigeriaVIH/sidapublié 2023BMJ global healthPubMeddocument de 4 observations
1,1 daysThe fever-clearance time in the CQ-CP-SP group was 1.1 days with a standard deviation of 0.4 days.
Nigeriapaludismepublié 2000Annals of Tropical Medicine and ParasitologyOpenAlexdocument de 6 observations
0,6 %0.6% of mild-to-severe anaemia among children aged 6–59 months in Nigeria was attributable to sickle cell disease.
Nigeriaanémie · drépanocytoseobservé 2018publié 2022BMJ openeurope_pmcdocument de 6 observationsDOI 10.1136/bmjopen-2022-063369
0,51 odds_ratioWomen in the higher leisure-time physical activity quartiles (Q3–Q4) versus Q1 had lower odds of having breast cancer (OR = 0.51, 95% CI: 0.35–0.74).
Nigeriacancer du seinpublié 2022Cancer epidemiologyPubMeddocument de 9 observations
12,6 odds_ratioPersons with diabetic foot ulcers were 12.6 times more likely to have deficient/insufficient vitamin D levels, with a 95% confidence interval of 6.0 to 26.2.
Nigeriapied diabétiquepublié 2025West African journal of medicinePubMeddocument de 5 observations
1,3 mmol/LThe mean HDL level among hypertensive patients was 1.3 ± 0.8 mmol/L, compared to 1.2 ± 0.3 mmol/L among diabetic patients.
Nigeriadiabète (non précisé) · hypertension artériellepublié 2023West African journal of medicinePubMeddocument de 9 observations
0,7 prevalence_ratioIn the North East geopolitical zone of Nigeria, the Mantel-Haenszel-adjusted prevalence ratio for malaria parasite prevalence between 2010 and 2018 was 0.70, indicating an overall reduction of more than 20%.
Nigeriapaludismeobservé 2010 to 2018publié 2021BMJ global healtheurope_pmcdocument de 8 observationsDOI 10.1136/bmjgh-2020-004250
1,73 daysParasite clearance time was 1.73 days in the seven chloroquine-treatment failures successfully treated with 25 mg kg−1 mefloquine.
Nigeriapaludismepublié 1992Annals of Tropical Medicine and ParasitologyOpenAlexdocument de 19 observations
25,6 %State-level antiretroviral therapy (ART) coverage among adults living with HIV in Nigeria ranged from 25.6% to 76.9% based on data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) conducted from July to December 2018.
NigeriaVIH/sidaobservé 2018publié 2022PloS onePubMeddocument de 5 observations
18 %The most common serotypes were 14 (18%, n=35), 6B (16%, n=31), 1 (9%, n=17), 5 (9%, n=17) and 6A (9%, n=17).
Nigeriapneumococcal disease · serotype 14publié 2023Microbial genomicsPubMeddocument de 10 observations
87,5 %Among 57 HIV-infected, HIV-exposed infants in Plateau State, Nigeria, 87.5% achieved viral suppression.
NigeriaVIH/sidaobservé 2018–2022publié 2026PloS onePubMeddocument de 13 observations
58 %Among breast cancer cases recorded by the Edo-Benin Cancer Registry (EBCR) from 2016 to 2018, 58% of those detected clinically were assigned to palliative care.
Nigeriacancer du seinobservé 2016 to 2018publié 2025Cancer causes & control : CCCPubMeddocument de 9 observations
11 %The case fatality rate of patients with endocrine diseases who had COVID-19 was 11%.
NigeriaCOVID-19 · endocrine diseasespublié 2023West African journal of medicinePubMeddocument de 9 observations
49 000 deaths_per_yearNigeria has the second highest pneumococcal disease burden globally, with an estimated ~49,000 child deaths caused by pneumococcal infections each year.
Nigeriapneumococcal diseasepublié 2023Microbial genomicsPubMeddocument de 10 observations
Cervical cancer is the fourth most common cancer in women globally.
Nigeriacancer du col de l'utéruspublié 2023BMC women's healthPubMeddocument de 7 observations
0,77 odds_ratioChildren receiving only Day 1 sulfadoxine-pyrimethamine plus amodiaquine had odds of rapid diagnostic test-confirmed malaria of 0.77 (95% CI 0.42–1.42) compared to those receiving non-sulfadoxine-pyrimethamine plus amodiaquine.
Nigeriapaludismeobservé 2021, 2022publié 2024Tropical medicine & international health : TM & IHPubMeddocument de 7 observations
28 patientsThe medial limbus was involved in 28 (32.6%) patients with ocular surface squamous neoplasia.
Nigeriaocular surface squamous neoplasiapublié 2021International ophthalmologyPubMeddocument de 12 observations
5,1 %The prevalence of congenital malaria in Nigeria ranged from 5.1% to 96.3%.
Nigeriapaludismepublié 2025Malaria journalPubMeddocument de 2 observations
84 casesLate-appearing anaemia (LAA) occurred in 84 of 609 children treated with artemisinin-based combination therapies for uncomplicated falciparum malaria.
Nigeriapaludismepublié 2016BMC infectious diseaseseurope_pmcdocument de 7 observationsDOI 10.1186/s12879-016-1565-4
1,09 daysThe mean fever clearance time was 1.09 days in the mefloquine 25 mg kg−1 group.
Nigeriapaludismepublié 1992Annals of Tropical Medicine and ParasitologyOpenAlexdocument de 19 observations
26,9 %26.9% of respondents defined glaucoma as blindness.
Nigeriaglaucomapublié 2026BMC ophthalmologyPubMeddocument de 13 observations
20 per_1000The mean incidence of uncomplicated malaria was 20 cases per 1000 children aged 3–59 months in 2021.
Nigeriapaludismeobservé 2021publié 2025Malaria journalPubMeddocument de 4 observations
38,6 %Among long-distance truck drivers in Ekiti State, Nigeria, 38.6% had multiple sex partners in the past 6 months.
NigeriaVIH/sidaobservé 2019publié 2021The Nigerian postgraduate medical journalPubMeddocument de 7 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.